Key facts
- This page summarizes Todd A. Becker's Form 4 filing for Core Scientific, Inc./tx (CORZ).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 18:23.
Todd A. Becker - 03 Mar 2025 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)
- Reporting relationship
- Director
- Issuer ticker
- CORZ
- Reported as of
- 03 Mar 2025
- Net transaction value
- -$1,595,675
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 18:23:14 UTC
- Prior SEC filing
- 28 Jan 2025
- Next SEC filing
- 11 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd DuChene, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd A. Becker filed Form 4 for Core Scientific, Inc./tx (CORZ) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 28 Jan 2025.
- Current net transaction value: -$1,595,675.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CORZ
transaction
Common Stock
Sale
- Transaction value
- $1,443,214
- Shares
- -134,250
- Change %
- -41%
- Price
- $10.75
- Shares after
- 195,687
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CORZ
transaction
Derivative
Tranche 1 Warrants
Sale
- Transaction value
- $59,942
- Shares
- -10,763
- Change %
- -100%
- Price
- $5.57
- Shares after
- 0
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,763
- Exercise price
- $6.81
- Footnotes
- F2, F3
CORZ
transaction
Derivative
Tranche 2 Warrants
Sale
- Transaction value
- $42,366
- Shares
- -3,900
- Change %
- -43%
- Price
- $10.86
- Shares after
- 5,069
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,900
- Exercise price
- $0.0100
- Footnotes
- F4, F5
CORZ
transaction
Derivative
Tranche 2 Warrants
Sale
- Transaction value
- $50,152
- Shares
- -5,069
- Change %
- -100%
- Price
- $9.89
- Shares after
- 0
- Date
- 04 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,069
- Exercise price
- $0.0100
- Footnotes
- F4, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Footnote F2
Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
Footnote F3
The price reported is a weighted average price. These Tranche 1 Warrants were sold in multiple transactions at prices ranging from $5.56 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants sold at each separate price within such range.
Footnote F4
Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.
Footnote F5
The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $10.75 to $10.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
Footnote F6
The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $9.7867 to $9.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.